Efficiency trends in the Indian pharmaceutical industry in the new patent regime Online publication date: Tue, 06-Oct-2015
by Varun Mahajan; D.K. Nauriyal; S.P. Singh
International Journal of Business Performance Management (IJBPM), Vol. 16, No. 4, 2015
Abstract: This paper applies data envelopment analysis (DEA) to measure the efficiency of Indian pharmaceutical firms over the period of 2000-01 to 2010-11. The findings reveal that there has been less variation in the mean OTE and PTE scores across years. Further, overall inefficiency in the industry is found to be driven more by managerial inefficiency than the scale inefficiency. The paper identifies efficiency leaders and laggards by applying BCC model. The comparative analysis of efficiency results show that the efficiency scores varied across size, ownership and product-group. On an average, firms in large size, private foreign owned, and engaged in drug formulations have relatively performed better than their counterparts. The paper suggests that in the new patent regime, the possible strategy for the small firms may be to expand their plant size or to merge with large firms in order to improve their performance.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Business Performance Management (IJBPM):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook